mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.0015 |
1 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.00078 |
1 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.00066 |
1 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.00048 |
1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00045 |
1 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.00031 |
1 |